文献速递炎症性肠病消化道肿瘤与早癌

群体感应分子在长病程溃疡性结肠炎中升高并与结肠炎相关癌症发展相关

Quorum-Sensing Molecules Are Elevated in Long-Standing Ulcerative Colitis and Are Linked to the Development of Colitis-Associated Cancer.
PubMed 文献 · Gastroenterology · 2026-02-11

该研究探讨细菌群体感应分子(QSM)是否与溃疡性结肠炎(UC)患者结肠炎相关癌症(CAC)风险相关,并在小鼠模型中验证。结果显示UC患者血清短链AHL升高,炎症且病程≥10年者自身诱导剂-2升高;C6-scAHL可促进CAC小鼠肿瘤发展并驱动促炎促肿瘤细胞因子产生。

要点

  • UC患者血清短链AHL水平高于健康对照。
  • 炎症且病程≥10年的UC患者自身诱导剂-2水平升高。
  • C6-scAHL促进小鼠结肠肿瘤发展并增加促炎促肿瘤细胞因子。

核心结论

  • 细菌QSM C6-scAHL在具有CAC风险因素的UC患者中升高,可促进小鼠结肠肿瘤发展并驱动促炎促肿瘤细胞因子产生。

研究设计与样本

  • 分析UC患者血液样本及AOM-DSS CAC小鼠模型中的3类细菌QSM:短链AHL、长链AHL和自身诱导剂-2。
  • 在SPF和无菌CAC小鼠模型中给予C6-scAHL,检测QSM水平、肿瘤发展、微生物组和代谢组。
  • 使用小鼠和UC患者结肠类器官培养检测C6-scAHL驱动的细胞因子产生。

主要发现

  • UC患者血清短链AHL水平高于健康对照。
  • UC患者中,存在炎症且病程≥10年者自身诱导剂-2水平升高。
  • CAC小鼠模型全身给予C6-scAHL后肿瘤数量和大小增加,并伴与炎症状态相似的微生物组和代谢组变化。
  • 无菌小鼠给予C6-scAHL也促进肿瘤发展。
  • 小鼠和UC患者结肠类器官中,C6-scAHL增加促肿瘤和促炎细胞因子产生。

临床怎么用

  • 提示细菌QSM可能作为UC患者CAC风险的潜在生物标志物或干预靶点,但尚需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chronic colonic inflammation can lead to colitis-associated cancer (CAC) in ulcerative colitis (UC) patients. The host-microbiome interface plays a critical role in CAC development. Quorum-sensing molecules (QSMs) are bacterial products that regulate bacterial processes. We investigated whether QSMs are related to risk factors for CAC in UC patients and drive CAC development in mouse models. METHODS: Blood samples from UC patients and mouse models of CAC (azoxymethane-dextran sodium sulfate) were analyzed for 3 bacterial QSM classes: short-chain n-acyl homoserine lactones (scAHLs) and long-chain n-acyl homoserine lactones and autoinducer-2. CAC mouse models (specific pathogen-free and germ-free) were challenged with C6-scAHL. QSM levels, colitis-associated tumor development, microbiome composition, and metabolome profiles were examined. Murine and human colonic organoid cultures were used to examine C6-scAHL-driven cytokine production. RESULTS: Serum scAHL levels were higher in UC patients than in healthy controls. UC patients with inflammation and ≥10 years of disease had elevated autoinducer-2 levels. Systemic C6-scAHL administration to a CAC mouse model increased tumor number and size and was associated with microbiome and metabolome changes similar to those in inflammatory settings. C6-scAHL administration also promoted tumor development in germ-free mice. In colonoids derived from mice and UC patients, C6-scAHL increased tumorigenic and proinflammatory cytokine production. CONCLUSIONS: The bacterial QSM C6-scAHL is elevated in UC patients with CAC risk factors. C6-scAHL promotes colon tumor development in mice and drives proinflammatory and protumorigenic cytokine production in vitro. Our findings highlight a previously unexplored pathogenetic pathway linking the microbiome to CAC development and suggest targets to modify CAC risk.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. O'Connor G, Hazime H, Burgueño JF, et al. Quorum-Sensing Molecules Are Elevated in Long-Standing Ulcerative Colitis and Are Linked to the Development of Colitis-Associated Cancer. Gastroenterology. 2026. PMID: 41687743. doi:10.1053/j.gastro.2026.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。